Clinical parameters of therapeutic apheresis induction in clinically amyopathic dermatomyositis patients with rapid progressive interstitial lung disease-Reference-Cited by-同舟云学术

Clinical parameters of therapeutic apheresis induction in clinically amyopathic dermatomyositis patients with rapid progressive interstitial lung disease

Published:2022-06-27 Issue:1 Volume:27 Page:152-158
ISSN:1744-9979
Container-title:Therapeutic Apheresis and Dialysis
language:en
Short-container-title:Ther Apher Dial

Author:

Kagitani Maki¹^ORCID,Nomi Hayahito¹,Azuma Haruhito¹

Affiliation:

1. Blood Purification Center Osaka Medical and Pharmaceutical University Hospital Takatsuki Japan

Publisher

Wiley

Subject

Nephrology,Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1744-9987.13898

Reference30 articles.

1. Would a new name hasten the acceptance of amyopathic dermatomyositis (dermatomyositis siné myositis) as a distinctive subset within the idiopathic inflammatory dermatomyopathies spectrum of clinical illness?

2. Corticosteroid resistant interstitial pneumonitis in dermatomyositis/polymyositis: prediction and treatment with cyclosporine;Nawata Y;J Rheumatol,1999

3. Increased ferritin predicts development and severity of acute interstitial lung disease as a complication of dermatomyositis

4. Pre-Treatment Ferritin Level and Alveolar-Arterial Oxygen Gradient Can Predict Mortality Rate Due to Acute/Subacute Interstitial Pneumonia in Dermatomyositis Treated by Cyclosporine A/Glucocorticosteroid Combination Therapy: A Case Control Study

5. Initial predictors of poor survival in myositis-associated interstitial lung disease: a multicentre cohort of 497 patients

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effectiveness and safety of plasma exchange for anti‐MDA5 antibody–positive clinically amyopathic dermatomyositis with rapidly progressive interstitial lung disease refractory to intensive immune suppression therapy: A case series;Therapeutic Apheresis and Dialysis;2024-01-15

2. Clinical application of blood purification in polymyositis/dermatomyositis;Therapeutic Apheresis and Dialysis;2023-10-18